Abstract
Influenza is a common disease in the population. Influenza vaccination is performed routinely and is usually well tolerated. Minor local or systemic side effects like fever and myalgia are described. Rarely there are more severe adverse events. Systemic vasculitis has been reported in some cases. In this case we report on a female patient with secondary vasculitis and myocardial infarction after influenza vaccination. The patient received cortisol and recovered. The literature about influenza vaccination, its side effects and recommendations about vaccination in patients with coronary artery disease is reviewed.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use
-
Adult
-
Aspirin / therapeutic use
-
Coronary Artery Disease / diagnosis
-
Coronary Artery Disease / drug therapy
-
Coronary Artery Disease / etiology*
-
Cortisone / therapeutic use
-
Diagnosis, Differential
-
Drug Therapy, Combination
-
Electrocardiography / drug effects
-
Female
-
Heparin / therapeutic use
-
Humans
-
Influenza Vaccines / adverse effects*
-
Myocardial Infarction / diagnosis
-
Myocardial Infarction / drug therapy
-
Myocardial Infarction / etiology*
-
Vasculitis / diagnosis
-
Vasculitis / drug therapy
-
Vasculitis / etiology*
Substances
-
Adrenergic beta-Antagonists
-
Influenza Vaccines
-
Heparin
-
Aspirin
-
Cortisone